Yes. Reaxys provides links to Scopus for all matching articles.

Reaxys differs from CrossFire Commander in:

1. Presentation of content. Reaxys is based on the combined content of CrossFire Beilstein, Gmelin and the Patent Chemistry Database (PCD). The data are standardized and harmonized. Substance (reaction) data from all three sources are merged into one substance (reaction) record.

2. Interface. The Commander interface was mainly functionality driven (e.g. sort, group), highly-sophisticared, but not really easy to use. The Reaxys interface is task-driven (e.g. define a reaction query, get reaction results, refine on reaction properties and output into PDF), intuitive to use and provides a streamlined look and feel, making searches easier.

3. Functionality. We have been careful to ensure that all the key functionality that our users value in Commander are carried through to Reaxys, but made much easier to use and more visible. In addition we have taken the opportunity to add improved search, analysis and workflow tools that are designed around the needs of users. These include:

• Synthesis planner
• Additional search capabilities (e.g. generate structure query from name)
• Intelligent hit ranking and filtering tools
• Smart results visualization (e.g. tabular display)
• Web-application: no client installation on user PC
• Support of Apple Macintosh and OpenURL

We have been careful to bring across all of the key functionality valued by core CrossFire Commander users. Our focus is on serving the needs of research chemists and we have prioritized the inclusion of content and functionality that supports this group. We are continuously developing the interface and will provide more functionality with every release.

Yes, in many cases. However, a web environment is always different from a client-server system, which could affect results display times.

To the contrary – Reaxys includes more and different features without losing any of the previous functionality.

At  www.info.reaxys.com (SUPPORT -> WEBINARS) you will find the registration form for the on-demand Reaxys webinars.

You can also make use of the Reaxys Training Center, where you can download a number of Reaxys tutorials.

Reaxys supports the following structure editors:

- Marvin Sketch (ChemAxon) - default structure editor
- ISIS/Draw (Symyx)
- Symyx Draw (Symyx)
- CrossFire Structure Editor (Elsevier)

Please note: if you wish to use other structure editors than Marvin Sketch, a plug-in has to be installed. This can be downloaded from http://www.info.reaxys.com/support_downloads.

Please refer to Reaxys' help system for more information on this topic.

Elsevier has matched the Reaxys compounds with two databases containing information about commercial availability: eMolecules and Symyx ACD (Available Chemicals Directory). In case of a successful match, icons are displayed by the compound within the Reaxys interface and a click on such an icon leads to the corresponding service.

Please note: access to ACD data is provided through Symyx' DiscoveryGate and requires a valid license to this service. Please contact Symyx for more details about ACD on DiscoveryGate.

Yes. The full text-link in Reaxys gives direct access to the publisher home pages including ScienceDirect (world's largest electronic collection of science, technology and medicine full-text and bibliographic information - owned by Elsevier) and EspaceNet (European Patent Office) and US Patent Office. Access to ScienceDirect and other literature publisher requires a subscription license. EspaceNet and USPTO are publicly available. 

Reaxys does not feature AutoNom and has no plans to do so. This is because tools which can generate an IUPAC name for a given structure are typically available in the structure editors with which Reaxys is compatible with (such as ChemDraw and Symyx Draw). The standard structure editor MarvinSketch from ChemAxon within Reaxys also contains this feature and is accessible through the menu item Tools -> Naming.

Please note: AutoNom is a 3rd party tool owned by the Beilstein Institute.